Abbott Commits to Reducing Malnutrition Globally with Launch of Abbott Center for Malnutrition Solutions

- Abbott (NYSE: ABT) announced today the creation of the Abbott Center for Malnutrition Solutions, an innovation hub focused on reducing malnutrition around the world. The center, a collaboration between Abbott and external nutrition experts and partners, will focus on the identification, treatment and prevention of malnutrition for the most vulnerable populations in the world, including mothers, infants and young children; aging adults; and people without access to good nutrition.

The work of the center will contribute to Abbott's 2030 Sustainability Plan ambition to transform care for malnutrition, chronic disease and infectious diseases, with a goal to improve the lives of more than 3 billion people by decade's end.

''Malnutrition affects 1 in 3 people around the world, and it's not only a result of extreme poverty," said Daniel Salvadori , executive vice president of Abbott's nutrition business. "It affects people of all ages, all geographies and all socioeconomic classes. Progress to address malnutrition is slow and has been exacerbated by the COVID-19 pandemic. Abbott has long been focused on improving nutrition through our innovations. The creation of the Abbott Center for Malnutrition Solutions will enable us to apply our science and expertise in collaboration with others to improve systems and ensure good nutrition is accessible to more people around the world."

A worldwide problem
Malnutrition affects people in all communities around the world and takes many forms.

The problem is extremely complex. Countries are simultaneously fighting the burdens of hunger, stunting, wasting and obesity. Conflict, environmental crises and economic instability play a role. Vulnerable groups continue to be disproportionately affected by these disruptions and lack of resources, impacting access to good nutrition and ultimately, improved outcomes.

"Reducing malnutrition around the world will require genuine partnerships with grassroots organizations and local leaders to gain a true understanding of what's needed on the ground, innovation to bring forward new ideas, and multi-sectoral partners working together to deliver collective impact and sustainable solutions," said Mary Pittman , DrPH, president and CEO, Public Health Institute.

Taking a different approach
The Abbott Center for Malnutrition Solutions will follow four key principles in its efforts to reduce malnutrition:

  • Convening the experts
    Abbott will cultivate conversations between the foremost experts in the fight against malnutrition. These conversations will look at malnutrition from different aspects, creating engaging discussions to understand the challenges, raise awareness of the problem and call on partners to work together to reduce malnutrition.

  • Co-creating solutions
    Given the many forms of malnutrition that are contributing to the crisis, solutions cannot be one-size-fits-all. Abbott is building an advisory board made up of experts from each region of the world to help understand the needs and nuances of malnutrition at a local level and connect with like-minded partners. Abbott will work with the private sector, governments, civil society organizations, multilaterals and entrepreneurs to co-design solutions. The United Nations Sustainable Development Goals — specifically No. 2: Zero Hunger, No. 3: Good Health and Wellbeing, and No. 17: Partnerships for the Goals — serve as a framework to provide goals and priorities for Abbott and its partners to reduce malnutrition and improve health.

  • Leveraging science and innovation
    Science and innovation are core to addressing malnutrition. Abbott has a long history of success in understanding the science behind nutrition and innovating to make nutrition accessible to people around the world. The company will leverage its learnings from previous work such as Nourimanba in Haiti , Ultra Rice in India , the MUAC z-score tape , and the Malnutrition Quality Improvement Initiative (MQii) as examples to guide its ongoing work.

  • Designing for sustainability
    Making a meaningful impact on malnutrition requires solutions that are sustainable and accessible. The ability to reach the people who need it and scale and replicate beyond a single project or donation will be key considerations when designing solutions and choosing partners.

For more information about the Abbott Center for Malnutrition Solutions please see https://www.abbott.com/malnutrition.html .

About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com , on LinkedIn at www.linkedin.com/company/abbott-/ , on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews .

i UNICEF; Child malnutrition. https://data.unicef.org/resources/jme-report-2021/
ii
WHO; Malnutrition. https://www.who.int/news-room/fact-sheets/detail/malnutrition
iii
UNICEF; Child malnutrition. https://data.unicef.org/resources/jme-report-2021/
iv
WHO; Malnutrition. https://www.who.int/news-room/fact-sheets/detail/malnutrition
v
UNICEF; Child malnutrition. https://data.unicef.org/resources/jme-report-2021/

Cision View original content: https://www.prnewswire.com/news-releases/abbott-commits-to-reducing-malnutrition-globally-with-launch-of-abbott-center-for-malnutrition-solutions-301388939.html

SOURCE Abbott

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)

Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO

"As previously disclosed, the Company believes that completing the full separation of its subsidiary, Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), makes strategic sense. The Bausch Health Board of Directors authorized management and management of its subsidiary, Bausch + Lomb, to explore a potential sale, which is one of several options being considered to complete the separation. That process is ongoing. No decision has been reached to proceed with any particular transaction, and there can be no assurance that it will result in a transaction.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Medtronic announces cash dividend for third quarter of fiscal year 2025

The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 5, 2024, approved the company's cash dividend for the third quarter of fiscal year 2025 of $0 .70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 47 consecutive years. The dividend is payable on January 10, 2025 to shareholders of record at the close of business on December 27, 2024 .

About Medtronic
Bold thinking. Bolder actions. We are Medtronic . Medtronic plc , headquartered in Galway , Ireland , is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic , visit www.Medtronic.com and follow Medtronic on LinkedIn .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Cardiex Limited (ASX:CDX)

Cardiex Limited


Keep reading...Show less

Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation Awareness Day

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), alongside the U.S. Pain Foundation (USPF), the International Foundation for Gastrointestinal Disorders (IFFGD), and the American Chronic Pain Association (ACPA) have united to recognize today, Thursday, December 5, as the second annual Opioid-Induced Constipation (OIC) Awareness Day. This important day is dedicated to bringing awareness to a commonly-overlooked side effect of opioids. By raising awareness and fostering open conversations, OIC Awareness Day seeks to reduce the stigma surrounding this condition and offer support to the many patients impacted by OIC

"As an organization dedicated to supporting individuals living with pain conditions, we're proud to participate in this year's OIC Awareness Day," said Kathy Sapp, CEO of ACPA. "By increasing awareness and improving communication between healthcare providers, patients, and caregivers, we can make a meaningful difference for those affected by this commonly occurring condition."

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected

FN Media Group News Commentary - Innovations in robotics technology, including artificial intelligence machine learning, and sensor technology, are enhancing the capabilities of medical robots. These advancements enable more precise surgical procedures, improved rehabilitation processes, and efficient hospital logistics, thus attracting more healthcare facilities to adopt robotic solutions. The market is characterized by a moderate level of merger and acquisition (M&A) activity by the leading players. This is due to several factors, including the desire to expand the business to cater to the growing demand for medical service robots. A report from Grand View Research said that the global medical service robots market size was estimated at USD 20.59 billion in 2024 and is projected to grow at a CAGR of 16.5% from 2025 to 2030. It said: "The growth can be attributed to the introduction of technologically advanced robotic equipment in the healthcare sector and the rise in per capita healthcare spending. Continuous advancements in technology, such as robotic catheter control systems (CCS), data recorders, data analytics, remote navigation, motion sensors, 3D-Imaging, and HD surgical microscopic cameras, are projected to drive industry growth. Furthermore, the introduction of swarm robotics is opening new opportunities for industry. It is a new approach to coordinating multi-robotic systems through swarm intelligence." Active Tech Companies in the markets today include Jeffs' Brands Ltd (NASDAQ: JFBR), Serve Robotics Inc. (NASDAQ: SERV), Symbotic Inc. (NASDAQ: SYM), Microbot Medical Inc. (NASDAQ: MBOT), Medtronic plc (NYSE: MDT).

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×